And Suggest Distinct Pathogenetic Mechanisms Takeshi Aoyama,* Uta Francke,4911 Harry C

Total Page:16

File Type:pdf, Size:1020Kb

And Suggest Distinct Pathogenetic Mechanisms Takeshi Aoyama,* Uta Francke,4911 Harry C Quantitative Differences in Biosynthesis and Extracellular Deposition of Fibrillin in Cultured Fibroblasts Distinguish Five Groups of Marfan Syndrome Patients and Suggest Distinct Pathogenetic Mechanisms Takeshi Aoyama,* Uta Francke,4911 Harry C. Dietz,l and Heinz Furthmayr* *Departments of Pathology, tGenetics, §Pediatrics, I1Howard Hughes Medical Institute, Stanford University, Stanford, California 94305; and IDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 Abstract musculoskeletal, and cardiovascular systems ( 1). Several years ago, Sakai et al. (2) isolated fibrillin from the culture medium Pulse-chase studies of [3S]cysteine-labeled fibrillin were of dermal fibroblasts and provided substantial evidence for this performed on fibroblast strains from 55 patients with Mar- protein to be the major component of 10-nm microfibrils. Mi- fan syndrome (MFS), including 13 with identified mutations crofibrils are abundant in elastic and non-elastic tissues in or- in the fibrillin-1 gene and 10 controls. Quantitation of the gans that are significantly affected in patients with the Marfan soluble intracellular and insoluble extraceliular fibrillin al- syndrome. A dramatic decrease in the amount of such microfi- lowed discrimination of five groups. Groups I (n = 8) and brils has previously been demonstrated in the skin and in cul- H (n = 19) synthesize reduced amounts of normal-sized tured fibroblasts from such patients (3). fibrillin, while synthesis is normal in groups m (n = 6), Genetic linkage studies with random probes mapped the IV (n = 18), and V (n = 4). When extracellular fibrillin MFS locus to chromosome 15 (4). The fibrillin cDNA was deposition is measured, groups I and III deposit between 35 cloned (5) and mapped to the same site on human chromosome and 70% of control values, groups II and IV < 35%, and 15 by in situ hybridization (6). Subsequently, genetic linkage group V > 70%. was established between the Marfan syndrome and the fibrillin A deletion mutant with a low transcript level from the gene (FBNI) on chromosome 15 by using intragenic markers mutant allele and seven additional patients have the group (7). Several unique and independent missense, nonsense, and I protein phenotype. Disease in these patients is caused by deletion mutations in FBNJ have been reported, which make a a reduction in microfibrils associated with either a null al- strong argument for the primary involvement of this large gene lele, an unstable transcript, or an altered fibrillin product in the causation of MFS (8-14). The basis for considerable synthesized in low amounts. In 68% of the MFS individuals intra- and interfamilial phenotypic variability remains unknown. (groups II and IV), a dominant negative effect is invoked Unique beaded microfibrils (2, 3, 15) are the presumptive func- as the main pathogenetic mechanism. Products made by the tional units that are affected. Even though the beaded microfibril mutant allele in these fibroblasts are proposed to interfere presumably contains other proteins in addition to fibrillin ( 16), with microfibril formation. Insertion, deletion, and exon all linkage studies and mutational analyses to date point to the skipping mutations, resulting in smaller fibrillin products, FBN1 gene as the major locus responsible for the phenotype. exhibit the group II phenotype. A truncated form of fibrillin MFS is an autosomal dominant disorder in patients hetero- of 60 kD was identified with specific fibrillin antibodies in zygous for mutations at the FBNJ locus and, therefore, the one of the group II cell culture media. Seven of the nine normal allele is expected to produce fibrillin mRNA of normal known missense mutations, giving rise to abnormal, but nor- size and amount. It is not known whether null mutations exist mal-sized fibrillin molecules, are in group IV. (J. Clin. In- and cause MFS that do not produce mutant fibrillin and that vest. 1994. 94:130-137.) Key words: fibrillin biosynthesis e allow unimpeded matrix deposition of wild-type fibrillin made dominant negative mutation * FBNJ * extracellular matrix from the normal allele. In contrast, a mutant allele that gives * elastin-associated microfibril rise to defective fibrillin molecules could interfere with normal fibrillogenesis and affect the integrity of the microfibrils by a Introduction dominant negative mechanism (17), similar to that postulated of No direct The Marfan syndrome (MFS)' is a systemic disorder of connec- for certain types osteogenesis imperfecta (18). tive tissue and its clinical features involve primarily the ocular, evidence has been provided as yet, however, to prove that this mechanism plays a role in the pathogenesis of MFS. McGookey Milewicz et al. (19) have previously reported variable abnor- T. Aoyama's present address is Third Division, Department of Internal malities in cultured fibroblasts from patients with MFS with Medicine, Faculty of Medicine, Kyoto University, Kyoto 606, Japan. respect to the rate of synthesis, secretion and the amount of Address correspondence to H. Furthmayr, Department of Pathology, fibrillin in the extracellular matrix. Implied pathogenetic mecha- Stanford University, 300 Pasteur Drive, Stanford, CA 94305-5324. nisms were not correlated with genotype. In a recent study we Received for publication 14 January 1994 and in revised form 23 have determined that missense mutations involving cysteine March 1994. residues in the FBNJ gene result in delayed fibrillin secretion, but this may not be the most important effect of such muta- 1. Abbreviation used in this paper: MFS, Marfan syndrome. tions (20). J. Clin. Invest. Here we report a comprehensive study of 55 fibroblast © The American Society for Clinical Investigation, Inc. strains from clinically well characterized MFS patients by quan- 0021-9738/94/07/0130/08 $2.00 titative pulse-chase methods. Based on the amounts of newly Volume 94, July 1994, 130-137 synthesized cellular fibrillin and the insoluble extracellular frac- 130 Aoyama et al. tion deposited during the 20-h chase period, five cellular pheno- A B C types were distinguished. Correlation of genotype to cellular and clinical phenotype suggests that FBNJ mutations cause dis- woo ease by different pathogenetic mechanisms. WO..1.1~~~~~~~.... Methods Studypopulation. Patients (n = 55), who satisfied the diagnostic criteria T(h) 04 8 20 8 20 4 8 20 established by Beighton et al. (21), and 10 normal controls were se- Cell ECM Medium lected for from the Marfan Clinic of the study Syndrome Stanford 1. the Northern California of the Figure Synthesis, secretion, and incorporation of fibrillin into the University Hospital, Chapter National extracellular matrix cultured control Marfan Association and the Johns Medical Center by fibroblasts. In A and B., cells Hopkins (Baltimore, were labeled with These include nine fibroblast with [355]cysteine and fibrillin was isolated from the cul- MD). strains missense mutations ture medium (A, left lane) and the cell lysate (B, left lane) by (20) and four with various other mutations as described purifica- recently (11, tion using a monoclonal antibody immunoaffinity column (A and B, 13, 14). right lanes) and samples were analyzed SDS-PAGE and Cell culture and Skin were by autoradiog- pulse-chase labeling. biopsy samples raphy. In C, cell lysate (Cell), NP-40 insoluble matrix components obtained under an from and controls either approved protocol patients (ECM) and tissue culture medium of control fibroblasts are at cardiovascular or visits. Dermal fibroblast (Medium) surgery during outpatient shown that were for 30 min and chased for or 20 h cultures were established in Dulbecco's modified medium pulse-labeled 4, 8, Eagle's (T[h]). Most of the newly synthesized and labeled fibrillin (F), col- (DME) with 15% fetal calf serum (FCS). The procedures used for pulse-chase lected after the 30-min pulse at time 0, is secreted from the cells during labeling, analysis by SDS-polyacrylamide gelectrophoresis the 4-8-h chase period. It accumulates in the medium that time and were done as described during (SDS-PAGE) quantitation recently (20). and a fraction of the labeled molecules is incorporated into the extracel- column. Monoclonal antibodies to fibrillin Immunoaffinity (mAb69 lular matrix within 8-20 h. was and donated Dr. L. Health Science Univer- Fibrillin quantitated in 30-min cell 201, kindly by Sakai, Oregon lysates (synthesis) and 20 h ECM (deposition) and not in the were to CNBr-activated media, sity, Portland, OR) coupled Sepharose (Phar- because the latter showed too much variability (not shown). macia Fine Chemicals, Piscataway, NJ) as described previously (2). Cell culture medium was incubated with antibodies coupled to Sepha- rose for 3 h at room temperature. The gel was then washed extensively with 50 mM Tris-HCl, pH 7.5, containing 0.5 M NaCl and 0.05% Tween value±2 SD, Table I; see data presented below in Figs. 2 and 20. Bound material was eluted from the column with 1 M acetic acid 3 A). Likewise, "decreased deposition" was defined as the and immediately neutralized with 4 M Tris, followed by dialysis against amount of fibrillin incorporated into the extracellular matrix phosphate buffered saline (PBS). The eluates were analyzed by SDS- being < 70% of controls (control value±2 SD, Table I; com- PAGE as described (20). pare also Figs. 2 and 3 B). In control fibroblasts, the amount of intracellular fibrillin after a 4-h chase was 18±4.8% com- Results pared with that at time 0. When > 30% of fibrillin
Recommended publications
  • Loss of Skin Elasticity Is Associated with Pulmonary Emphysema, Biomarkers of Inflammation, and Matrix Metalloproteinase Activity in Smokers Michael E
    O’Brien et al. Respiratory Research (2019) 20:128 https://doi.org/10.1186/s12931-019-1098-7 RESEARCH Open Access Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers Michael E. O’Brien1, Divay Chandra1, Robert C. Wilson1, Chad M. Karoleski1, Carl R. Fuhrman2, Joseph K. Leader2, Jiantao Pu2, Yingze Zhang1, Alison Morris1,3, Seyed Nouraie1, Jessica Bon1,4, Zsolt Urban5 and Frank C. Sciurba1* Abstract Background: Elastin breakdown and the resultant loss of lung elastic recoil is a hallmark of pulmonary emphysema in susceptible individuals as a consequence of tobacco smoke exposure. Systemic alterations to the synthesis and degradation of elastin may be important to our understanding of disease phenotypes in chronic obstructive pulmonary disease. We investigated the association of skin elasticity with pulmonary emphysema, obstructive lung disease, and blood biomarkers of inflammation and tissue protease activity in tobacco-exposed individuals. Methods: Two hundred and thirty-six Caucasian individuals were recruited into a sub-study of the University of Pittsburgh Specialized Center for Clinically Orientated Research in chronic obstructive pulmonary disease, a prospective cohort study of current and former smokers. The skin viscoelastic modulus (VE), a determinant of skin elasticity, was recorded from the volar forearm and facial wrinkling severity was determined using the Daniell scoring system. Results: In a multiple regression analysis, reduced VE was significantly associated with cross-sectional measurement of airflow obstruction (FEV1/FVC) and emphysema quantified from computed tomography (CT) images, β = 0.26, p = 0.001 and β = 0.24, p = 0.001 respectively.
    [Show full text]
  • Determination of the Molecular Basis of Marfan Syndrome: a Growth Industry
    Determination of the molecular basis of Marfan syndrome: a growth industry Peter H. Byers J Clin Invest. 2004;114(2):161-163. https://doi.org/10.1172/JCI22399. Commentary Although it has been known for more than a decade that Marfan syndrome — a dominantly inherited connective tissue disorder characterized by tall stature, arachnodactyly, lens subluxation, and a high risk of aortic aneurysm and dissection — results from mutations in the FBN1 gene, which encodes fibrillin-1, the precise mechanism by which the pleiotropic phenotype is produced has been unclear. A report in this issue now proposes that loss of fibrillin-1 protein by any of several mechanisms and the subsequent effect on the pool of TGF-β may be more relevant in the development of Marfan syndrome than mechanisms previously proposed in a dominant-negative disease model. The model proposed in this issue demonstrates several strategies for clinical intervention. Find the latest version: https://jci.me/22399/pdf Commentaries Determination of the molecular basis of Marfan syndrome: a growth industry Peter H. Byers Departments of Pathology and Medicine, University of Washington, Seattle, Washington, USA. Although it has been known for more than a decade that Marfan syndrome In this issue of the JCI, Judge and colleagues — a dominantly inherited connective tissue disorder characterized by tall test the hypothesis that haploinsufficiency is stature, arachnodactyly, lens subluxation, and a high risk of aortic aneurysm the major effect rather than the dominant- and dissection — results from mutations in the FBN1 gene, which encodes negative effect expected with multimeric pro- fibrillin-1, the precise mechanism by which the pleiotropic phenotype is teins (14).
    [Show full text]
  • Fibrillin and Elastin Expression in Skin Regenerating from Cultured
    Fibrillin and Elastin Expression in Skin Regenerating Frotn Cultured Keratinocyte Autografts: Morphogenesis of Microfibrils Begins At the Dertno-epidertnal Junction and Precedes Elastic Fiber Fortnation Michael Raghunath, Thomas Bachi, * Martin Meuli, -r Stefan Altermatt, t l:tita Gobet, t Leena Bruckner-Tuderman,:j: and Beat SteinmalID tDivision of Metabolj c and Molecular Disease and Pedi atric Bum Ccnter of the Ulljvcrsity Children's Hospital Ztirich, "' Electron microscopic Central Laboratory of the University of Ziirich, Switzerland; and t Departlllcnt of Dermatology at the University of Mtinstcr, F.R.G. The tetnporo-spatial expression of fibrillin and elas­ horizontailly undulating microfibrils of the neoder­ tin in skin regenerating frotn autologous keratino­ mis which had developed independently. Elastin was cyte grafts was studied in three burned children. Skin first identified in the deeper neodermis 1 month after biopsies taken between 5 days and 17 months after grafting as granular aggregates and 4 months after grafting were investigated by conventional immuno­ grafting on fibrillar structures and surrounding cap­ fluorescence, confocal laser scanning, and electron illaries of the upper neodermis. Association of elastin microscopy. Fibrillin, the major component of 10- with microfibrils in the papillary dermis was not 12-nm microfibrils, appeared 5 days after grafting in detectable before month 17. Our findings suggest a band-like fashion similar to collagen VII at the that the cutaneous microfibrillar apparatus develops prospective basctnent membrane, and then formed simultaneously at both the dermo-epidermal junc­ the characteristic tnicrofibrillar candelabra at the tion and the reticular dermis and is a prerequisite for dermo-epidermal junction by fusion of several fine elastic fiber formation.
    [Show full text]
  • RIN2 Deficiency Results in Macrocephaly, Alopecia, Cutis Laxa
    REPORT RIN2 Deficiency Results in Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis: MACS Syndrome Lina Basel-Vanagaite,1,2,14 Ofer Sarig,4,14 Dov Hershkovitz,6,7 Dana Fuchs-Telem,2,4 Debora Rapaport,3 Andrea Gat,5 Gila Isman,4 Idit Shirazi,4 Mordechai Shohat,1,2 Claes D. Enk,10 Efrat Birk,2 Ju¨rgen Kohlhase,11 Uta Matysiak-Scholze,11 Idit Maya,1 Carlos Knopf,9 Anette Peffekoven,12 Hans-Christian Hennies,12 Reuven Bergman,8 Mia Horowitz,3 Akemi Ishida-Yamamoto,13 and Eli Sprecher2,4,6,* Inherited disorders of elastic tissue represent a complex and heterogeneous group of diseases, characterized often by sagging skin and occasionally by life-threatening visceral complications. In the present study, we report on an autosomal-recessive disorder that we have termed MACS syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis). The disorder was mapped to chromosome 20p11.21-p11.23, and a homozygous frameshift mutation in RIN2 was found to segregate with the disease phenotype in a large consan- guineous kindred. The mutation identified results in decreased expression of RIN2, a ubiquitously expressed protein that interacts with Rab5 and is involved in the regulation of endocytic trafficking. RIN2 deficiency was found to be associated with paucity of dermal micro- fibrils and deficiency of fibulin-5, which may underlie the abnormal skin phenotype displayed by the patients. Disorders of elastic tissue often share common phenotypic shown to result in decreased secretion of elastin.9,10 In features, including redundant skin, hyperlaxity of joints, addition,
    [Show full text]
  • Quantitative Differences in Biosynthesis and Extracellular Deposition of Fibrillin in Cultured Fibroblasts Distinguish Five Grou
    Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. T Aoyama, … , H C Dietz, H Furthmayr J Clin Invest. 1994;94(1):130-137. https://doi.org/10.1172/JCI117298. Research Article Pulse-chase studies of [35S]cysteine-labeled fibrillin were performed on fibroblast strains from 55 patients with Marfan syndrome (MFS), including 13 with identified mutations in the fibrillin-1 gene and 10 controls. Quantitation of the soluble intracellular and insoluble extracellular fibrillin allowed discrimination of five groups. Groups I (n = 8) and II (n = 19) synthesize reduced amounts of normal-sized fibrillin, while synthesis is normal in groups III (n = 6), IV (n = 18), and V (n = 4). When extracellular fibrillin deposition is measured, groups I and III deposit between 35 and 70% of control values, groups II and IV < 35%, and group V > 70%. A deletion mutant with a low transcript level from the mutant allele and seven additional patients have the group I protein phenotype. Disease in these patients is caused by a reduction in microfibrils associated with either a null allele, an unstable transcript, or an altered fibrillin product synthesized in low amounts. In 68% of the MFS individuals (groups II and IV), a dominant negative effect is invoked as the main pathogenetic mechanism. Products made by the mutant allele in these fibroblasts are proposed to interfere with microfibril formation. Insertion, deletion, and exon skipping mutations, resulting in smaller fibrillin products, exhibit the group II phenotype. A truncated form of fibrillin of 60 kD was […] Find the latest version: https://jci.me/117298/pdf Quantitative Differences in Biosynthesis and Extracellular Deposition of Fibrillin in Cultured Fibroblasts Distinguish Five Groups of Marfan Syndrome Patients and Suggest Distinct Pathogenetic Mechanisms Takeshi Aoyama,* Uta Francke,4911 Harry C.
    [Show full text]
  • Quantifying the Biomechanical Forces Between Proteins
    QUANTIFYING THE BIOMECHANICAL FORCES BETWEEN PROTEINS INVOLVED IN ELASTIN SYNTHESIS USING ATOMIC FORCE MICROSCOPY SEAN O’NEILL MOORE Bachelor of Science in Mechanical Engineering University of Notre Dame May 2015 Submitted in partial fulfillment of requirement for the degree MASTER OF SCIENCE IN BIOMEDICAL ENGINEERING at the CLEVELAND STATE UNIVERSITY December 2018 We hereby approve this thesis for SEAN O’NEILL MOORE Candidate for the Master of Science in Biomedical Engineering for the Department of Chemical and Biomedical Engineering and the CLEVELAND STATE UNIVERSITY’S College of Graduate Studies by Committee Chairperson, Dr. Chandrasekhar Kothapalli Department & Date Committee Member, Dr. Nolan Holland Department & Date Committee Member, Dr. Jason Halloran Department & Date Date of Defense: November 19, 2018 ACKNOWLEDGMENT First and foremost, I would like to thank Dr. Chandrasekhar Kothapalli for being my advisor throughout my biomedical engineering career at Cleveland State. I have learned many valuable skill sets and a more in depth appreciation for biomaterials and biomechanics under his guidance. This knowledge reaches far beyond that of teaching and I appreciate his insights. In addition, I would like to thank Dr. Nolan Holland of the Chemical and Biomedical Engineering Department, and Dr. Jason Halloran from the Mechanical Engineering Department for their invaluable advice and input on the project and taking the time to be a part of my thesis committee. Additionally, I would like to thank the Chemistry Department at Cleveland State as well as Dr. Holland’s Lab at Cleveland State for allowing me to utilize equipment necessary to run my experiments. I also want to thank the Baldock Lab at the University of Manchester in Manchester, England, for the generous gift of Fibulin-5.
    [Show full text]
  • The Microfibril-Elastin Fiber System Distribution in Left Atrioventricular Valve of the Rat
    Int. J. Morphol., 29(3):907-913, 2011. The Microfibril-Elastin Fiber System Distribution in Left Atrioventricular Valve of the Rat Distribución del Sistema de Microfibrillas y fibras de Elastina en la Valva Atrioventricular Izquierda de la Rata *Vinícius Novaes Rocha; *Rodrigo Neto-Ferreira; **Carlos Alberto Mandarim-de-Lacerda & *Jorge José de Carvalho ROCHA, V. N.; NETO-FERREIRA, R.; MANDARIM-DE-LACERDA & CARVALHO, J. J. The microfibril-elastin fiber system distribuition in left atrioventricular valve of the rat. Int. J. Morphol., 29(3):907-913, 2011. SUMMARY: The microfibril-elastin fiber system, an important constituent of the extracellular matrix, was studied in the rat left atrioventricular valve to investigate the interrelationship of oxytalan, elaunin and elastic fibers in left atrioventricular valve morphology. The elastin fibers forms continuous bundles observed along the length of the valve in atrial and ventricular layers and oriented parallel to endothelium. The elaunin and oxytalan fibers are distributed in the thickest fiber bundles along the length of the valve. The thinner fibers which radiated towards both the atrial and spongiosa layers, either as isolated or arborescent fiber bundles were identified as oxytalan fibers. With transmission electron microscopy elastic fibers were seen mainly in the atrial layer. The spongiosa layer was composed of elaunin and oxytalan fibers and ventricular layer showed elaunin fibers arranged in continuous bundles parallel to the endothelium. Both fibrillin and elastin were seen and identified by immunocytochemistry with colloidal gold in the left atrioventricular valve spongiosa and atrial layers. These observations allow us to suggest that the microfibril-elastin fiber system plays a role in the mechanical protection and maintenance of the integrity of the rat left atrioventricular valve.
    [Show full text]
  • Evidence for a Critical Contribution of Haploinsufficiency in the Complex Pathogenesis of Marfan Syndrome Daniel P
    Research article Related Commentary, page 161 Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome Daniel P. Judge,1 Nancy J. Biery,2 Douglas R. Keene,3 Jessica Geubtner,1 Loretha Myers,2 David L. Huso,4 Lynn Y. Sakai,3 and Harry C. Dietz2,5 1Division of Cardiology and 2McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 3Shriners Hospital for Children, Oregon Health and Science University, Portland, Oregon, USA. 4Department of Comparative Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 5Howard Hughes Medical Institute, Bethesda, Maryland, USA. Marfan syndrome is a connective tissue disorder caused by mutations in the gene encoding fibrillin-1 (FBN1). A dominant-negative mechanism has been inferred based upon dominant inheritance, mulitimer- ization of monomers to form microfibrils, and the dramatic paucity of matrix-incorporated fibrillin-1 seen in heterozygous patient samples. Yeast artificial chromosome–based transgenesis was used to overexpress a disease-associated mutant form of human fibrillin-1 (C1663R) on a normal mouse background. Remarkably, these mice failed to show any abnormalities of cellular or clinical phenotype despite regulated overexpression of mutant protein in relevant tissues and developmental stages and direct evidence that mouse and human fibrillin-1 interact with high efficiency. Immunostaining with a human-specific mAb provides what we believe to be the first demonstration that mutant fibrillin-1 can participate in productive microfibrillar assembly. Informatively, use of homologous recombination to generate mice heterozygous for a comparable missense mutation (C1039G) revealed impaired microfibrillar deposition, skeletal deformity, and progressive dete- rioration of aortic wall architecture, comparable to characteristics of the human condition.
    [Show full text]
  • Proteolysis of Fibrillin-2 Microfibrils Is Essential for Normal Skeletal Development
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.03.429587; this version posted February 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development Timothy J. Meada, Daniel R. Martina, Lauren W. Wanga, Stuart A. Cainb, Cagri Gulecc, Elisabeth Cahilla, Joseph Maucha, Dieter P. Reinhardtd, Cecilia W. Loc, Clair Baldockb, Suneel S. Aptea1 aDepartment of Biomedical Engineering and Musculoskeletal Research Center, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195; bDivision of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; cDepartment of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15201, dDepartment of Anatomy and Cell Biology and Faculty of Dentistry, McGill University, Montreal, Quebec, Canada. Short title: ADAMTS proteostasis of microfibrils 1To whom correspondence should be addressed: Suneel S. Apte, MBBS, D.Phil., Department of Biomedical Engineering-ND20, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Phone: 216.445.3278; E-mail: [email protected] Classification: BIOLOGICAL SCIENCES – Developmental Biology (or Cell Biology) Key words: ADAMTS, metalloproteinase, limb development, skeletal development, extracellular matrix, microfibrils, fibrillin, Marfan syndrome, Weill-Marchesani syndrome. 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.03.429587; this version posted February 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • Human Microfibrillar-Associated Protein 4 (MFAP4) Gene Promoter
    International Journal of Molecular Sciences Article Human Microfibrillar-Associated Protein 4 (MFAP4) Gene Promoter: A TATA-Less Promoter That Is Regulated by Retinol and Coenzyme Q10 in Human Fibroblast Cells Ying-Ju Lin 1,2, An-Ni Chen 3, Xi Jiang Yin 4, Chunxiang Li 4 and Chih-Chien Lin 3,* 1 School of Chinese Medicine, China Medical University, Taichung 40447, Taiwan; [email protected] 2 Genetic Center, Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan 3 Department of Cosmetic Science, Providence University, Taichung 43301, Taiwan; [email protected] 4 Advanced Materials Technology Centre, Singapore Polytechnic, Singapore 139651, Singapore; [email protected] (X.J.Y.); [email protected] (C.L.) * Correspondence: [email protected]; Tel.: +886-4-26328001; Fax: +886-4-26311167 Received: 8 October 2020; Accepted: 4 November 2020; Published: 9 November 2020 Abstract: Elastic fibers are one of the major structural components of the extracellular matrix (ECM) in human connective tissues. Among these fibers, microfibrillar-associated protein 4 (MFAP4) is one of the most important microfibril-associated glycoproteins. MFAP4 has been found to bind with elastin microfibrils and interact directly with fibrillin-1, and then aid in elastic fiber formation. However, the regulations of the human MFAP4 gene are not so clear. Therefore, in this study, we firstly aimed to analyze and identify the promoter region of the human MFAP4 gene. The results indicate that the human MFAP4 promoter is a TATA-less promoter with tissue- and species-specific properties. Moreover, the promoter can be up-regulated by retinol and coenzyme Q10 (coQ10) in Detroit 551 cells.
    [Show full text]
  • Marfan Syndrome in the Third Millennium
    European Journal of Human Genetics (2002) 10, 673 – 681 ª 2002 Nature Publishing Group All rights reserved 1018 – 4813/02 $25.00 www.nature.com/ejhg REVIEW Marfan syndrome in the third Millennium Gwenae¨lle Collod-Be´roud1 and Catherine Boileau*,1,2 1INSERM U383, Universite´ Paris V, Hoˆpital Necker-Enfants Malades, 149-161 rue de se`vres, 75743 Paris Cedex 15, France; 2Laboratoire de Biochimie, d’Hormonologie et de Ge´ne´tique Mole´culaire, Hoˆpital Ambroise Pare´ AP-HP, 9 av Charles de Gaulle, 92104 Boulogne Cedex, France The Marfan syndrome (MFS) is a prominent member of heritable disorders of connective tissue with manifestations involving primarily the skeletal, ocular and cardiovascular systems but also and less systematically investigated the lung, skin and integument, and dura. Over the last two decades, a considerable amount of clinical, molecular and protein data had accumulated. In combination with the study of natural and transgenic animal models, this new information provides greater insight into the pathogenic mechanisms underlying not only the pleiotropic manifestations of MFS but also the important degree of clinical variability (age of onset and severity) observed between patients. The following aspects will be described in this review: the structure and function of fibrillin-1; the fibrillin proteins; mutations in the FBN1 gene and pathogenic mechanisms; animal models. Finally, the currently available laboratory diagnostic tests and their limits will be discussed. European Journal of Human Genetics (2002) 10, 673 – 681. doi:10.1038/sj.ejhg.5200876 Keywords: Marfan syndrome; MFS; FBN1; fibrillin-1; review; structure Introduction guish classic Marfan syndrome from many related A hundred years have now elapsed since Dr Antonin disorders.
    [Show full text]
  • Fibrillin-Rich Microfibrils: Elastic Biopolymers of the Extracellular Matrix
    Journal of Muscle Research and Cell Motility 23: 581–596, 2002. 581 Ó 2003 Kluwer Academic Publishers. Printed in the Netherlands. Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix C. M. KIELTY1,*, T. J. WESS3, L. HASTON3, JANE L. ASHWORTH2, M. J. SHERRATT2 and C. A. SHUTTLEWORTH2 1School of Medicine; 2School of Biological Sciences, University of Manchester, 2.205 Stopford Building, Oxford Road, Manchester M13 9PT, UK; 3School of Biological Sciences, University of Stirling FK9 4LA, UK Abstract Fibrillin-rich microfibrils are evolutionarily ancient macromolecular assemblies of the extracellular matrix. They have unique extensible properties that endow vascular and other tissues with long-range elasticity. Microfibril extensibility supports the low pressure closed circulations of lower organisms such as crustaceans. In higher vertebrates, microfibrils act as a template for elastin deposition and are components of mature elastic fibres. In man, the importance of microfibrils is highlighted by the linkage of mutations in their principal structural component, fibrillin-1, to the heritable disease Marfan syndrome which is characterised by severe cardiovascular, skeletal and ocular defects. When isolated from tissues, fibrillin-rich microfibrils have a complex ultrastructural organisation with a characteristic ‘beads-on-a-strong’ appearance. X-ray fibre diffraction studies and biomechanical testing have shown that microfibrils are reversibly extensible at tissue extensions of 100%. Ultrastructural analysis and 3D reconstructions of isolated microfibrils using automated electron tomography have revealed new details of how fibrillin molecules are aligned within microfibrils in untensioned and extended states, and delineated the role of calcium in regulating microfibril beaded periodicity, rest length and molecular organisation. The molecular basis of how fibrillin molecules assemble into microfibrils, the central role of cells in regulating this process, and the identity of other molecules that may coassemble into microfibrils are now being elucidated.
    [Show full text]